Thomas U. Ahearn
Staff Scientist
EPIDEMIOLOGY AND BIOSTATISTICS PROGRAM
National Cancer Institute
United States of America
Biography
Dr. Ahearn received an M.P.H in epidemiology from the Rollins School of Public Health, Emory University, in 2006 and a Ph.D. in nutrition and health sciences, epidemiology track, from the Graduate Division Biological and Biomedical Sciences, Emory University, in 2012. His dissertation was titled “The investigation and development of dietary and life-style modifiable, pre-neoplastic biomarkers of risk for colorectal neoplasms.” Upon completion of his Ph.D., he became a postdoctoral fellow and most recently, a research associate in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health. In September 2016, Dr. Ahearn joined the Epidemiology and Biostatistics Program as a staff scientist, where he will be working under the direction of Dr. Montserrat García-Closas to support her program of integrative molecular epidemiology research
Research Interest
pathways and risk factors for cancer; development of primary and secondary cancer prevention; novel treatment strategies
Publications
-
Ahearn TU, Tchrakian N, Wilson KM, Lis R, Nuttall E, Sesso HD, Loda M, Giovannucci E, Mucci LA, Finn S, Shui IM. Calcium-sensing receptor tumor expression and lethal prostate cancer progression. The Journal of Clinical Endocrinology & Metabolism. 2016 Jun 1;101(6):2520-7.
-
Graff RE, Judson G, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A. Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2: ERG. The Prostate. 2017 May 1;77(6):647-53.
-
Dickerman BA, Ahearn TU, Giovannucci E, Stampfer MJ, Nguyen PL, Mucci LA, Wilson KM. Weight change, obesity, and risk of prostate cancer progression among men with clinically localized prostate cancer. International Journal of Cancer. 2017 May 23.
